Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Hillengaß, Jens [VerfasserIn]   i
 Usmani, Saad [VerfasserIn]   i
 Goldschmidt, Hartmut [VerfasserIn]   i
Titel:International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
Verf.angabe:Jens Hillengass, Saad Usmani, S Vincent Rajkumar, Brian G M Durie, María-Victoria Mateos, Sagar Lonial, Cristina Joao, Kenneth C Anderson, Ramón García-Sanz, Eloísa Riva Serra, Juan Du, Niels van de Donk, Jesús G Berdeja, Evangelos Terpos, Elena Zamagni, Robert A Kyle, Jesús San Miguel, Hartmut Goldschmidt, Sergio Giralt, Shaji Kumar, Noopur Raje, Heinz Ludwig, Enrique Ocio, Rik Schots, Hermann Einsele, Fredrik Schjesvold, Wen-Ming Chen, Niels Abildgaard, Brea C Lipe, Dominik Dytfeld, Baldeep Mona Wirk, Matthew Drake, Michele Cavo, Juan José Lahuerta, Suzanne Lentzsch
E-Jahr:2019
Jahr:29 May 2019
Umfang:11 S.
Teil:volume:20
 year:2019
 number:6
 pages:302-312
 extent:11
Fussnoten:Gesehen am 25.06.2019
Titel Quelle:Enthalten in: The lancet <London> / Oncology
Ort Quelle:London : The Lancet Publ. Group, 2000
Jahr Quelle:2019
Band/Heft Quelle:20(2019), 6, Seite 302-312
ISSN Quelle:1474-5488
Abstract:Summary - Recent advances in the treatment of multiple myeloma have increased the need for accurate diagnosis of the disease. The detection of bone and bone marrow lesions is crucial in the investigation of multiple myeloma and often dictates the decision to start treatment. Furthermore, detection of minimal residual disease is important for prognosis determination and treatment planning, and it has underscored an unmet need for sensitive imaging methods that accurately assess patient response to multiple myeloma treatment. Low-dose whole-body CT has increased sensitivity compared with conventional skeletal survey in the detection of bone disease, which can reveal information leading to changes in therapy and disease management that could prevent or delay the onset of clinically significant morbidity and mortality as a result of skeletal-related events. Given the multiple options available for the detection of bone and bone marrow lesions, ranging from conventional skeletal survey to whole-body CT, PET/CT, and MRI, the International Myeloma Working Group decided to establish guidelines on optimal use of imaging methods at different disease stages. These recommendations on imaging within and outside of clinical trials will help standardise imaging for monoclonal plasma cell disorders worldwide to allow the comparison of results and the unification of treatment approaches for multiple myeloma.
DOI:doi:10.1016/S1470-2045(19)30309-2
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag ; Resolving-System: https://doi.org/10.1016/S1470-2045(19)30309-2
 Volltext: http://www.sciencedirect.com/science/article/pii/S1470204519303092
 DOI: https://doi.org/10.1016/S1470-2045(19)30309-2
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1667878735
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68400978   QR-Code
zum Seitenanfang